LBF20207PG41: Difference between revisions
m (LBF20307PG26 moved to LBF20207PG41) |
No edit summary |
||
Line 5: | Line 5: | ||
|LipidMaps=LMFA03010102 | |LipidMaps=LMFA03010102 | ||
|SysName=9a,15R-dihydroxy-11-oxo-prosta-5E,13E-dien-1-oic acid | |SysName=9a,15R-dihydroxy-11-oxo-prosta-5E,13E-dien-1-oic acid | ||
|Common Name=&&15 (R) -Prostaglandin | |Common Name=&&15 (R) -Prostaglandin D_2&& | ||
}} | }} |
Revision as of 07:33, 19 December 2008
IDs and Links | |
---|---|
LipidBank | XPR1772 |
LipidMaps | LMFA03010102 |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG41 |
15 (R) -Prostaglandin D2 | |
---|---|
Structural Information | |
9a,15R-dihydroxy-11-oxo-prosta-5E,13E-dien-1-oic acid | |
| |
Formula | C20H32O5 |
Exact Mass | 352.224974134 |
Average Mass | 352.46508 |
SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)C(C[C@@H]1O)=O)CC |
Physicochemical Information | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|